When blood transfusion medicine becomes complicated due to interference by monoclonal antibody therapy-Reference-Cited by-同舟云学术

When blood transfusion medicine becomes complicated due to interference by monoclonal antibody therapy

Published:2015-05-18 Issue:6pt2 Volume:55 Page:1555-1562
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Oostendorp Marlies¹,Lammerts van Bueren Jeroen J.²,Doshi Parul³,Khan Imran³,Ahmadi Tahamtan³,Parren Paul W.H.I.²⁴,van Solinge Wouter W.¹,De Vooght Karen M.K.¹

Affiliation:

1. Department of Clinical Chemistry and Haematology; University Medical Center Utrecht

2. Genmab; Utrecht The Netherlands

3. Janssen R&D LLC; Spring House (Ambler) Pennsylvania

4. Department of Immunohematology and Blood Transfusion; Leiden University Medical Center; Leiden The Netherlands

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/trf.13150/fullpdf

Reference13 articles.

1. Novel human antibody therapeutics: the age of the Umabs;Ruuls;Biotechnol J,2008

2. Detection of a monoclonal antibody therapy (ofatumumab) by serum protein and immunofixation electrophoresis;Genzen;Br J Haematol,2011

3. Interference of monoclonal antibody therapies with serum protein electrophoresis tests;McCudden;Clin Chem,2010

4. Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors;Weers;J Immunol,2011

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Valutazione di un metodo commerciale basato sull'utilizzo del CD38 solubile per mitigare l'interferenza del daratumumab sui test pre-trasfusionali;La Rivista Italiana della Medicina di Laboratorio;2024-09

2. Blood group genotype matching for transfusion;British Journal of Haematology;2024-08-05

3. Is drug interference still an issue for pretransfusion testing of patients on anti CD38 and other monoclonal antibody therapies?;Vox Sanguinis;2024-05-05

4. Risk of new alloimmunization in patients on anti-CD38 treatment using tube LISS-IAT method;Transfusion and Apheresis Science;2024-04

5. A Brief Report on Pre-Transfusion Testing in Patients Receiving the Anti-CD38 Monoclonal Antibody for Hematological Disorders in India;Indian Journal of Hematology and Blood Transfusion;2024-04-01